Coronavirus: Latest global developmentsThursday, April 22, 2021
KINGSTON, Jamaica – Here are the latest developments in the coronavirus crisis, compiled by the AFP.
-India posted a global record of 314,835 new infections in the past 24 hours – the most of any country since the pandemic began – as hospitals sent out desperate warnings that patients could die without fresh oxygen supplies.
-Tokyo Olympics organisers reported the first infection from the nationwide torch relay as the pandemic continues to play havoc with the Games, which are scheduled to take place this summer.
- Fake doses of the Pfizer vaccine have been sold in Mexico and Poland for as much as $2,500 a shot, the US drugmaker and an official confirmed.
-An unvaccinated worker infected with a COVID variant sparked an outbreak at a US nursing home where nearly all the residents had been inoculated, according to research released by the US Centers for Disease Control and Prevention.
-After an international mission to China turned up more questions than answers about the pandemic origins, the World Health Organization is evaluating how to move forward through a diplomatic quagmire to solve the mystery.
-French-Austrian vaccine developer Valneva announced it has launched a Phase 3 trial of its candidate vaccine – the last testing stage before seeking regulatory approval.
-The US will offer tax credits to businesses that grant their employees time off to receive a COVID-19 vaccine or recover from its side effects.
At least 3,060,859 people have died of COVID-19 around the world since the outbreak emerged in China in December 2019, according to a tally from official sources compiled by AFP.
The United States is the worst-affected country with 569,404 deaths, followed by Brazil with 381,475, Mexico with 213,597, India with 184,657 and Britain with 127,327.
Now you can read the Jamaica Observer ePaper anytime, anywhere. The Jamaica Observer ePaper is available to you at home or at work, and is the same edition as the printed copy available at https://bit.ly/epaper-login